Early clinical manifestations associated with death from visceral leishmaniasis

PLoS Neglected Tropical Diseases

Volumn 6, Issue 2, 2012, Pages

  de Araújo, Valdelaine Etelvina Miranda ^a,b   Morais, Maria Helena Franco ^a,b   Reis, Ilka Afonso ^c   Rabello, Ana ^d   Carneiro, Mariângela ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Centro de Controle de Zoonoses   (Brazil)

^c Inst Cie Exatas Univ Fed M   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; MEGLUMINE ANTIMONATE; PENTAMIDINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLEEDING; BRAZIL; CHILD; COHORT ANALYSIS; COUGHING; DATA BASE; DEATH; DIAGNOSTIC TEST ACCURACY STUDY; EDEMA; FATALITY; FEMALE; FEVER; HEPATOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; INFECTION; JAUNDICE; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SCORING SYSTEM; SPLENOMEGALY; TUBERCULOSIS; VISCERAL LEISHMANIASIS; WEAKNESS; WEIGHT REDUCTION; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK FACTOR; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84857822649     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001511     Document Type: Article

References (43)

1. WHO, (2008) The global burden of disease: 2004 update. Available http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf. Acessed 2011 Jan 19.
2. WHO, (2010) First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. Available: http://whqlibdoc.who.int/publications/2010/9789241564090_eng.pdf. Acessed 2011 January 19.
3. Romero GA, Boelaert M, (2010) Control of visceral leishmaniasis in latin america-a systematic review. PLoS Negl Trop Dis 4: e584.
4. Werneck GL, Batista MS, Gomes JR, Costa DL, Costa CH, (2003) Prognostic factors for death from visceral leishmaniasis in Teresina, Brazil. Infection 31: 174-177.
5. Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, et al. (1997) Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10: 298-319.
6. Bern C, Maguire JH, Alvar J, (2008) Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2: e313.
7. Desjeux P, (2001) Worldwide increasing risk factors for leishmaniasis. Med Microbiol Immunol 190: 77-79.
8. Oliveira AL, Paniago AM, Dorval ME, Oshiro ET, Leal CR, et al. (2006) [Emergent outbreak of visceral leishmaniasis in Mato Grosso do Sul State]. Rev Soc Bras Med Trop 39: 446-450.
9. Profeta da Luz ZM, Pimenta DN, Cabral AL, Fiuza VO, Rabello A, (2001) [Leishmaniasis urbanization and low diagnosis capacity in the Metropolitan Region of Belo Horizonte]. Rev Soc Bras Med Trop 34: 249-254.
10. Jeronimo SM, Oliveira RM, Mackay S, Costa RM, Sweet J, et al. (1994) An urban outbreak of visceral leishmaniasis in Natal, Brazil. Trans R Soc Trop Med Hyg 88: 386-388.
11. Arias JR, Monteiro PS, Zicker F, (1996) The reemergence of visceral leishmaniasis in Brazil. Emerg Infect Dis 2: 145-146.
12. Ministry of Health of Brazil (2009) Guia de vigilância epidemiológica. 7a edition. Brasília. Available http://portal.saude.gov.br/portal/arquivos/pdf/gve_7ed_web_atual.pdf. Acessed 2011 January 19.
13. Ministry of Health of Brazil (2010) Casos confirmados de Leishmaniose Visceral, Brasil, Grandes Regiões e Unidades Federadas. 1990 a 2009. Available: http://dtr2004.saude.gov.br/sinanweb/tabnet/dh?sinannet/leishvi/bases/leishvbrnet.def. Accessed 2010 December 10.
14. Ministry of Health of Brazil (2010) Letalidade por Leishmaniose Visceral. Brasil, Grandes Regiões e Unidades Federadas, 2000 a 2009. Available: http://dtr2004.saude.gov.br/sinanweb/tabnet/dh?sinannet/leishvi/bases/leishvbrnet.def. Accessed 2010 December 10.
15. Zerpa O, Ulrich M, Borges R, Rodriguez V, Centeno M, et al. (2003) Epidemiological aspects of human and canine visceral leishmaniasis in Venezuela. Rev Panam Salud Publica 13: 239-245.
16. Maia-Elkhoury AN, Carmo EH, Sousa-Gomes ML, Mota E, (2007) [Analysis of visceral leishmaniasis reports by the capture-recapture method]. Rev Saude Publica 41: 931-937.
17. Brasil, (2006) Manual de vigilância e controle da leishmaniose visceral, 1th ed. Secretaria de Vigilância em Saúde. Available at: http://portal.saude.gov.br/portal/arquivos/pdf/manual_leish_visceral2006.pdf. Accessed 2010 December 8.
18. Dye C, (1996) The logic of visceral leishmaniasis control. Am J Trop Med Hyg 55: 125-130.
19. Brasil, (2006) Leishmaniose visceral grave: normas e condutas. Secretaria de Vigilância em Saúde. Available at: http://portal.saude.gov.br/portal/arquivos/pdf/manual_lv_grave_nc.pdf. Acessed 2011 January 19.
20. Harway MO, Olliaro PL, Costa DL, Costa CHN, (2011) Urban parasitology:visceral leishmaniasis inBrazil. Trends in Parasitology.
21. Brasil, (2000) Censo Demográfico 2010. Instituto Brasileiro de Geografia e Estatística, http://www.ibge.gov.br/home/estatistica/populacao/censo2010/tabelas_pdf/total_populacao_minas_gerais.pdf. Accessed: 2011 February 10.
22. Barquet N, Domingo P, Caylà JA, González J, Rodrigo C, et al. (1997) Prognostic factors in meningococcal disease: development of a beside predictive model an scoring system. JAMA 278: 491-496.
23. Szklo M, Javier Nieto F, (2007) Epidemiology: beyond the basis Aspen Gaithersburg.
24. Oliveira JM, Fernandes AC, Dorval ME, Alves TP, Fernandes TD, et al. (2010) [Mortality due to visceral leishmaniasis: clinical and laboratory characteristics]. Rev Soc Bras Med Trop 43: 188-193.
25. Costa CHN, Werneck GL, Costa DL, Holanda TA, Aguiar GB, et al. (2010) Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Revista da Sociedade Brasileira de Medicina Tropical 43: 386-392.
26. Sampaio MJAQ, Cavalcanti NV, Alves JGB, Fernandes Filho MJC, Correia JB, (2010) Risk factors for death in children with visceral leishmaniasis. PLoS Negl Trop Dis 4: e877.
27. Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL, (1996) Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources. Ann Intern Med 124: 664-672.
28. Collin S, Davidson R, Ritmeijer K, Keus K, Melaku Y, et al. (2004) Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin Infect Dis 38: 612-619.
29. Kajaia M, Morse DL, Kamkamidize G, Butsashvili M, Chubabria G, et al. (2011) Risk factors for relapse of visceral leishmaniasis in Georgia. Tropical Medicine and International Health 16: 186-192.
30. Abdelmoula MS, M'Hamdi Z, Amri F, Tebib N, Ben Turkia H, et al. (2003) [Visceral leishmaniasis in children: prognostic factors]. Tunis Med 81: 535-539.
31. Duarte MI, Corbett CE, (1987) Histopathological patterns of the liver involvement in visceral leishmaniasis. Rev Inst Med Trop Sao Paulo 29: 131-136.
32. Hervas JA, Alberti P, Ferragut J, Canet R, (1991) Acute hepatitis as a presenting manifestation of kala azar. Pediatr Infect Dis J 10: 409-410.
33. Mueller Y, Mbulamberi DB, Odermatt P, Hoffmann A, Loutan L, et al. (2009) Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda. Trop Med Int Health 14: 910-917.
34. Andrade TM, Carvalho EM, Rocha H, (1990) Bacterial infections in patients with visceral leishmaniasis. J Infect Dis 162: 1354-1359.
35. Lomtadze ML, Khochava MA, Shalamberidze IA, Kharaishvili VI, Vorob'eva EO, (2005) [Study of intravascular coagulation activation markers in patients with visceral leishmaniasis]. Georgian Med News pp. 47-50.
36. Esmon C, (2004) The impact of the inflammatory response on coagulation. Thromb Res 114: 321-327.
37. Cota GF, Sousa MR, Rabello A, (2011) Predictors of Visceral Leishmaniasis Relapse in HIV Infected Patients: A Systematic Review. PLoS Negl Trop Dis 5: e1153.
38. Alvar J, Aparicio P, Aseffa A, Den Boer M, Canavate C, et al. (2008) The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334-359.
39. Choi CM, Lerner EA, (2001) Leishmaniasis as an emerging infection. J Investig Dermatol Symp Proc 6: 175-182.
40. Chaisson RE GJ, Keruly JC, Moore RD, (1998) Impact of opportunistic disease on survival in patients with HIV infection. AIDS 12: 29-33.
41. Cruz I, Nieto J, Moreno J, Canavate C, Desjeux P, et al. (2006) Leishmania/HIV co-infections in the second decade. Indian J Med Res 123: 357-388.
42. Wolday D AH, Fessahaye G, Valantine A, Britton S, (1998) Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cells. Scand J Infect Dis 30: 29-34.
43. Silva FG, Tavares-Neto J, (2007) Avaliação dos Prontuários Médicos de Hospitais de Ensino do Brasil. Revista Brasileita de Educação Médica 29: 113-126.